• CME's Updated LSOC Phase 2 Schedule and Principles

      • To
      • Clearing Member Firms
      • From
      • CME Clearing
      • #
      • 13-064
      • Notice Date
      • 07 February 2013
      • Effective Date
      • 22 April 2013
    • This advisory provides updated information on CME’s implementation schedule for LSOC phase 2, often called "LSOC with excess", "LSOC with client-specific value reporting", or "LSOC with client-specific excess."
       
      CME Clearing will begin allowing firms to operate in LSOC phase 2 mode – LSOC with daily client-specific collateral value reporting – on Monday, April 22, 2013.
       
      There is no requirement that firms begin operating in LSOC with excess mode on that date, and we anticipate a transition process occurring over a period of several months, as firms test and go live with LSOC phase 2.  CME has not established a date by which firms must convert, and may allow firms to continue operating in LSOC phase 1 mode indefinitely.
       
      Firms may begin testing their submissions of daily collateral value reports at any time. We expect full-scale parallel testing to begin with a subset of firms around March 1.
       
       
      13-064

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2025 CME Group Inc. All rights reserved.